Resolution of Severe Anorexia Nervosa Associated with Gender Dysphoria (Dysphorexia) by Testosterone Therapy| Stephy Publishers
SOJ Diabetes and Endocrinology Care - (SOJDEC) | Stephy Publishers
Abstract
Anorexia nervosa is a
severe and potentially lethal eating disorder. In transgender youth with severe
gender dysphoria, a severe eating disorder (proposed name: dysphorexia),
coherent with anorexia nervosa may be triggered by the desire to avoid the cisgender
pubertal transition. In these patients, gender-affirming hormone therapy can be
extremely effective. We report hereby the cases of two female-to-male
transsexual patients with severe gender dysphoria whose anorexia nervosa was
related to their pubertal development and who promptly recovered when they
started gender-affirming hormone therapy with testosterone, after very limited
success with standard psychotherapy and pharmacotherapy for anorexia nervosa.
Our patients could not access pubertal suppression due to lack of parental
consent in one case and failure to express the conflict in the other. We
postulate that avoiding the cisgender pubertal transition with GnRH agonist
treatment might also be able to prevent the development of dysphorexia.
Introduction
For many adolescents
with gender incongruence, the pubertal physical changes are a cause of intense
dysphoria and unbearable suffering.1 Early treatment
(typically beginning in the Tanner pubertal II stage) with GnRH analogues in
order to suppress puberty has been shown to improve psychological functioning
and physical outcome.2 Anorexia nervosa is a severe and
potentially lethal eating disorder, characterized by a restriction of energy
intake relative to requirements leading to an abnormally low body weight; an
intense fear of gaining weight and a distorted perception of body shape.3
The general cause of
anorexia nervosa is unknown,2 but in the case
of adolescent transgender people, a specific issue with the perception of body
shape and development is apparent. The restriction of energy intake (often
associated with excessive exercise, vomit induction or use of laxatives) may
impede or delay the pubertal development of the secondary sex characteristics
associated with gender dysphoria, alleviating the suffering of the patient.
Although the present American Psychological Association4 guidelines for practice with transgender and gender
nonconforming people do not mention anorexia nervosa, there appears to be a
higher prevalence of documented eating disorder symptoms in transgender youth
compared to cisgender youth.5 Reportedly,
transgender youth with eating disorders are at particularly high risk for
self-injury and suicidal behaviours.6,7 In a few of the
reported cases,8,9 the pathological eating behaviour of the
patients was explicitly reported as a way to manage gender expression
(menstruation cessation, loss of secondary sexual characters). In a report,
puberty suppression with a GnRH agonist quickly restored healthy eating habits
and normal psychological functioning in two transgender adolescents.10 There is also a paucity of reports of the effect of
gender-affirming therapy in post pubertal patients. In one case report, a
patient initially presented as a 16 year-old typical female with anorexia
nervosa was later revealed as a male transgender subject in whom treatment with
testosterone plus bilateral mastectomy alleviated his eating disorder.11 Another case report describes the partial recovery of a
19-year old female transgender subject with anorexia nervosa after she received
suppressive therapy with leuprolide and spironolactone, although she did not
receive estrogen therapy.12 The association between gender dysphoria
and eating disorders has been explored in two recent reviews13,14 but the conscious link between caloric restriction and the
avoidance of pubertal cisgender development has very rarely been reported.
To read more #Diabetes #EndocrinologyCare
https://www.stephypublishers.com/sojdec/fulltext/SOJDEC.MS.ID.000502.php
More #Openaccessjournals
https://www.stephypublishers.com/
Comments
Post a Comment